Market Overview

McNicoll Lewis & Vlak Raises PT on AMAG Pharmaceuticals to $23


McNicoll Lewis & Vlak has raised the price target on AMAG Pharmaceuticals (NASDAQ: AMAG) to $23 and maintains its Buy rating.

Posted-In: mcnicoll lewis vlakPrice Target Intraday Update Analyst Ratings


Related Articles (AMAG)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→